Branched chain amino acids in the management of chronic liver disease. Facts and fantasies.
The liver plays a central role in protein and amino acid metabolism. It processes dietary amino acids and reprocesses amino acids released from muscle protein degradation. It utilises amino acids for protein synthesis and gluconeogenesis, regulates the supply of amino acids to peripheral tissues and converts excess amino acids to urea. In patients with liver disease the liver's ability to control both plasma and tissue amino acid fluxes may be seriously disturbed. The resultant changes in amino acid metabolism may be implicated in the genesis of the neuropsychiatric abnormalities and the deterioration in nutritional status commonly observed in patients with hepatic failure. Thus, on theoretical grounds, amelioration of these amino acid abnormalities might benefit patients with liver disease who have hepatic encephalopathy or are malnourished. However, there is, at present, no consensus as to the efficacy, practicality or cost-effectiveness of 'amino acid therapy' in patients with liver disease.
Morgan
M Y
MY
Academic Department of Medicine, Royal Free Hospital and School of Medicine, Hampstead, London, United Kingdom.
D000597:Amino Acids, Branched-Chain / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*
D000597:Amino Acids, Branched-Chain